Search
GE Healthcare Technologies Inc
GEHCAdd to Watchlist
61.590USD
+0.440+0.72%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
28.02BMarket Cap
14.70P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of GE Healthcare Technologies Inc is 7.73, ranking 122 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 88.00, with a high of 108.00 and a low of 73.00.
Analyst Rating
Based on
21
analysts
Buy
Current Rating
81.475
Target Price
+33.24%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
94
Total
3
Median
7
Average
Company name
Ratings
Analysts
GE Healthcare Technologies Inc
GEHC
21
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
29
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is GE Healthcare Technologies Inc's expected revenue for the next quarter?
GE Healthcare Technologies Inc's expected revenue is 5.27B.
What is GE Healthcare Technologies Inc's price target?
Analysts forecast that GE Healthcare Technologies Inc's price target is USD 88.00, with the highest forecast at USD 108.00 and the lowest forecast at USD 73.00.
How have GE Healthcare Technologies IncGEHC's recent earnings per share performed?
The market expectation was USD 0.85, while GE Healthcare Technologies IncGEHC's earnings per share (EPS) for the previous quarter was USD 1.30. EPS for the next quarter is expected at USD 1.03.
What is the analyst rating for GE Healthcare Technologies Inc?
Based on the ratings of GE Healthcare Technologies Inc's stock from 21 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
